First Horizon Advisors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

First Horizon Advisors’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-351	Closed	-$40.6K	–	2486
2023 Q3	$40.6K	Sell	351 -29	-8%	-$3.12K	﹤0.01%	941
2023 Q2	$39.1K	Buy	380 +29	+8%	+$3.06K	﹤0.01%	996
2023 Q1	$38.3K	Sell	351 -20	-5%	-$2.21K	﹤0.01%	1005
2022 Q4	$42.2K	Hold	371	–	–	﹤0.01%	923
2022 Q3	$21K	Sell	371 -132	-26%	-$9.22K	﹤0.01%	1227
2022 Q2	$39K	Buy	503 +14	+3%	+$1.33K	﹤0.01%	1026
2022 Q1	$52K	Sell	489 -812	-62%	-$79.1K	﹤0.01%	638
2021 Q4	$140K	Sell	1,301 -82	-6%	-$8.95K	﹤0.01%	585
2021 Q3	$151K	Buy	1,383 +470	+51%	+$48.8K	﹤0.01%	563
2021 Q2	$84K	Sell	913 -80	-8%	-$7.36K	﹤0.01%	601
2021 Q1	$90K	Buy	993 +921	+1,279%	+$77.7K	0.01%	542
2020 Q4	$5K	Sell	72 -42	-37%	-$3.12K	﹤0.01%	1228
2020 Q3	$8K	Sell	114 -67	-37%	-$4.61K	﹤0.01%	1082
2020 Q2	$10K	Sell	181 -125	-41%	-$5.35K	﹤0.01%	1024
2020 Q1	$9K	Sell	306 -246	-45%	-$8.32K	﹤0.01%	972
2019 Q4	$20K	Hold	552	–	–	﹤0.01%	870
2019 Q3	$15K	Buy	+552	New	+$14.3K	﹤0.01%	962
2016 Q4	–	Sell	-415	Closed	-$6K	–	1470
2016 Q3	$6K	Hold	415	–	–	﹤0.01%	1119
2016 Q2	$6K	Hold	415	–	–	﹤0.01%	1089
2016 Q1	$5K	Buy	415 +388	+1,437%	+$6.79K	﹤0.01%	1153
2015 Q4	$0	Sell	27 -660	-96%	-$12.8K	﹤0.01%	1430
2015 Q3	$13K	Buy	687 +395	+135%	+$12.5K	﹤0.01%	928
2015 Q2	$10K	Buy	+292	New	+$8.91K	﹤0.01%	1033

Other funds holding HZNP

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return

FSWA

Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

First Horizon Advisors's HZNP Position: Q4 2023 in Review

First Horizon Advisors sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 351 shares — an estimated $40.6K sold.

First Horizon Advisors first reported a position in HZNP in Q2 2015 and held it in 23 quarters. The position peaked at $151K in Q3 2021. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

First Horizon Advisors reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
First Horizon Advisors sold 351 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $40.6K.
First Horizon Advisors first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2015 and held it in 23 quarters.
First Horizon Advisors's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $151K in Q3 2021.
6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on First Horizon Advisors's 13F filing for Q4 2023, filed 6 Feb 2024.